Literature DB >> 18297331

Neuroanatomy of pseudobulbar affect : a quantitative MRI study in multiple sclerosis.

Omar Ghaffar1, Laury Chamelian, Anthony Feinstein.   

Abstract

Pseudobulbar affect (PBA) is defined as episodes of involuntary crying, laughing, or both in the absence of a matching subjective mood state. This neuropsychiatric syndrome can be found in a number of neurological disorders including multiple sclerosis (MS). The aim of this study was to identify neuroanatomical correlates of PBA in multiple sclerosis (MS) using a case-control 1.5T MRI study. MS patients with (n = 14) and without (n = 14) PBA were matched on demographic, disease course, and disability variables. Comorbid psychiatric disorders including depressive and anxiety disorders were absent. Hypo- and hyperintense lesion volumes plus measurements of atrophy were obtained and localized anatomically according to parcellated brain regions. Between-group statistical comparisons were undertaken with alpha set at 0.01 for the primary analysis. Discrete differences in lesion volume were noted in six regions: Brainstem hypointense lesions, bilateral inferior parietal and medial inferior frontal hyperintense lesions, and right medial superior frontal hyperintense lesions were all significantly higher in the PBA group. A logistic regression model identified four of these variables (brainstem hypointense, left inferior parietal hyperintense, and left and right medial inferior frontal hyperintense lesion volumes) that accounted for 70% of the variance when it came to explaining the presence of PBA. In conclusion, MS patients with PBA have a distinct distribution of brain lesions when compared to a matched MS sample without PBA. The lesion data support a widely-dispersed neural network involving frontal, parietal, and brainstem regions in the pathophysiology of PBA.

Entities:  

Mesh:

Year:  2008        PMID: 18297331     DOI: 10.1007/s00415-008-0685-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  23 in total

1.  Regional frontal cortical volumes decrease differentially in aging: an MRI study to compare volumetric approaches and voxel-based morphometry.

Authors:  Danielle J Tisserand; Jens C Pruessner; Ernesto J Sanz Arigita; Martin P J van Boxtel; Alan C Evans; Jelle Jolles; Harry B M Uylings
Journal:  Neuroimage       Date:  2002-10       Impact factor: 6.556

2.  A robust method for extraction and automatic segmentation of brain images.

Authors:  N Kovacevic; N J Lobaugh; M J Bronskill; B Levine; A Feinstein; S E Black
Journal:  Neuroimage       Date:  2002-11       Impact factor: 6.556

3.  Abnormal pontine activation in pathological laughing as shown by functional magnetic resonance imaging.

Authors:  H Kosaka; N Omata; M Omori; T Shimoyama; T Murata; K Kashikura; T Takahashi; J Murayama; Y Yonekura; Y Wada
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12       Impact factor: 10.154

Review 4.  Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon-beta.

Authors:  W I McDonald; D H Miller; A J Thompson
Journal:  Ann Neurol       Date:  1994-07       Impact factor: 10.422

5.  Pathological laughing and crying in multiple sclerosis: a preliminary report suggesting a role for the prefrontal cortex.

Authors:  A Feinstein; P O'Connor; T Gray; K Feinstein
Journal:  Mult Scler       Date:  1999-04       Impact factor: 6.312

6.  Pathological laughter and crying: a link to the cerebellum.

Authors:  J Parvizi; S W Anderson; C O Martin; H Damasio; A R Damasio
Journal:  Brain       Date:  2001-09       Impact factor: 13.501

7.  Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group.

Authors:  R A Rudick; E Fisher; J C Lee; J Simon; L Jacobs
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

8.  Emotionalism after stroke.

Authors:  A House; M Dennis; A Molyneux; C Warlow; K Hawton
Journal:  BMJ       Date:  1989-04-15

9.  Mood disorder following cerebrovascular accident.

Authors:  M R Eastwood; S L Rifat; H Nobbs; J Ruderman
Journal:  Br J Psychiatry       Date:  1989-02       Impact factor: 9.319

10.  Structural brain abnormalities in multiple sclerosis patients with major depression.

Authors:  A Feinstein; P Roy; N Lobaugh; K Feinstein; P O'Connor; S Black
Journal:  Neurology       Date:  2004-02-24       Impact factor: 9.910

View more
  6 in total

1.  Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment.

Authors:  Ida S Haussleiter; Martin Brüne; Georg Juckel
Journal:  Ther Adv Neurol Disord       Date:  2009-01       Impact factor: 6.570

2.  Posterior Fossa Lesion Load and Pathological Laughing and Crying in Multiple Sclerosis.

Authors:  Jacqueline A Luhoway; Manas Sharma; Suresh Menon; Heather Rosehart; Sarah A Morrow
Journal:  Int J MS Care       Date:  2019 May-Jun

3.  Pseudobulbar laughter as a levodopa off phenomenon exacerbated by subthalamic deep brain stimulation.

Authors:  P K Chattha; P E Greene; Ritesh A Ramdhani
Journal:  J Clin Mov Disord       Date:  2015-08-14

4.  Why do mothers never stop grieving for their deceased children? Enduring alterations of brain connectivity and function.

Authors:  Sarah M Kark; Joren G Adams; Mithra Sathishkumar; Steven J Granger; Liv McMillan; Tallie Z Baram; Michael A Yassa
Journal:  Front Hum Neurosci       Date:  2022-09-02       Impact factor: 3.473

5.  Human ventromedial prefrontal lesions alter incentivisation by reward.

Authors:  Sanjay G Manohar; Masud Husain
Journal:  Cortex       Date:  2016-01-19       Impact factor: 4.027

6.  Widespread subcortical grey matter degeneration in primary lateral sclerosis: a multimodal imaging study with genetic profiling.

Authors:  Eoin Finegan; Stacey Li Hi Shing; Rangariroyashe H Chipika; Mark A Doherty; Jennifer C Hengeveld; Alice Vajda; Colette Donaghy; Niall Pender; Russell L McLaughlin; Orla Hardiman; Peter Bede
Journal:  Neuroimage Clin       Date:  2019-11-12       Impact factor: 4.881

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.